The results demonstrated that while p16 inactivation alone did not initiate tumorigenesis, combined with KRAS activation, it significantly accelerated tumor progression and metastasis, closely resembling human pancreatic ductal adenocarcinoma. This evidence concerns the gene KRAS and neoplasm.